Ever Valinject Gmbh
SpainAll drugs from this manufacturer
-
It is used to treat postmenopausal women with a type of estrogen receptor-positive breast cancer that is locally advanced or metastatic. It is also used in combination with palbociclib to treat women with hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or metastatic.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage fulvestrant 50.0 mg -
It is used in pregnant women (between weeks 24 and 33) to delay preterm labor by making uterine contractions less intense and less frequent.
Dosage form: solution for infusion, concentrate
Active substance Dosage atosiban acetate 7,50 mg -
It is used in pregnant women (between weeks 24 and 33) to help delay preterm labor by making uterine contractions less intense and less frequent.
Dosage form: solution for injection
Active substance Dosage atosiban acetate 7,50 mg -
It is used in pregnant women to delay preterm labor by making uterine contractions weaker and less frequent.
Dosage form: solution for injection
Active substance Dosage atosiban acetate 7,50 mg -
It is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a cancer that affects the lymph nodes) in adults.
Dosage form: solution for injection
Active substance Dosage bortezomib 2,5 mg/ml -
It is used to treat prostate cancer that has progressed after having received another type of chemotherapy. It works by slowing the growth and multiplication of cancer cells.
Dosage form: solution for infusion, concentrate
Active substance Dosage cabazitaxel 10 mg/ml -
It is used to provide conscious sedation (a state of calmness, drowsiness, or sleep) to adult patients in intensive care units or during surgical and diagnostic procedures.
Dosage form: solution for infusion, concentrate
Active substance Dosage dexmedetomidine hydrochloride 0,1182 mg -
It is used to treat adult patients with locally advanced or metastatic breast cancer (when other treatments have stopped working) and also to treat advanced or metastatic liposarcoma in adults when previous treatments have not been effective.
Dosage form: solution for injection
Active substance Dosage eribulin 0,44 mg/ml -
It is used for the short-term adjunctive treatment of heart failure in adults who continue to experience difficulty breathing despite taking other medications to remove fluids from the body.
Dosage form: solution for infusion, concentrate
Active substance Dosage levosimendan 2,5 mg/ml -
It is used for the treatment of cancer, specifically for malignant pleural mesothelioma (a type of cancer in the lung lining) and for advanced-stage lung cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage pemetrexed 25 mg/ml -
It is used to treat bleeding from dilated veins in the esophagus (bleeding esophageal varices) and for the emergency treatment of type 1 hepatorenal syndrome in patients with cirrhosis and ascites.
Dosage form: solution for injection
Active substance Dosage terlipressin acetate 0,17 mg -
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have experienced a relapse and are not resistant to platinum-based drugs.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 0,25 mg -
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have had a relapse and are not resistant to platinum compounds.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 1 mg